125 related articles for article (PubMed ID: 15178717)
1. Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients.
Deitcher SR; Fraschini G; Himmelfarb J; Schuman E; Smith TJ; Schulz GA; Firszt CM; Mouginis TL
J Vasc Interv Radiol; 2004 Jun; 15(6):575-80. PubMed ID: 15178717
[TBL] [Abstract][Full Text] [Related]
2. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
[TBL] [Abstract][Full Text] [Related]
3. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
[TBL] [Abstract][Full Text] [Related]
4. Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases.
Molinari AC; Haupt R; Saracco P; Di Marco M; Castagnola E; Fratino G
Support Care Cancer; 2004 Dec; 12(12):840-3. PubMed ID: 15365798
[TBL] [Abstract][Full Text] [Related]
5. Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion.
Teirstein PS; Mann JT; Cundey PE; Schechter E; Jacobs WC; Grines CL; Stagaman DJ; Lansky AJ; Hultquist MA; Kusnick BA; Heuser RR; Kleinert HD; Popma J
Am J Cardiol; 1999 Jun; 83(12):1623-8. PubMed ID: 10392865
[TBL] [Abstract][Full Text] [Related]
6. Intraluminal instillation of urokinase and autologous plasma: a method to unblock occluded central venous ports.
Seifert G; Riess H; Seeger K; Henze G; Borgmann A
BMC Cancer; 2006 Apr; 6():103. PubMed ID: 16635269
[TBL] [Abstract][Full Text] [Related]
7. High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters.
Twardowski ZJ
Am J Kidney Dis; 1998 May; 31(5):841-7. PubMed ID: 9590195
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
Ponec D; Irwin D; Haire WD; Hill PA; Li X; McCluskey ER;
J Vasc Interv Radiol; 2001 Aug; 12(8):951-5. PubMed ID: 11487675
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study.
Dillon PW; Jones GR; Bagnall-Reeb HA; Buckley JD; Wiener ES; Haase GM;
J Clin Oncol; 2004 Jul; 22(13):2718-23. PubMed ID: 15226339
[TBL] [Abstract][Full Text] [Related]
10. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
[TBL] [Abstract][Full Text] [Related]
11. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
12. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
[TBL] [Abstract][Full Text] [Related]
13. A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters.
Aquino VM; Sandler ES; Mustafa MM; Steele JW; Buchanan GR
J Pediatr Hematol Oncol; 2002 Dec; 24(9):710-3. PubMed ID: 12468909
[TBL] [Abstract][Full Text] [Related]
14. Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial.
Hartmann JR; McKeever LS; O'Neill WW; White CJ; Whitlow PL; Gilmore PS; Doorey AJ; Galichia JP; Enger EL
J Am Coll Cardiol; 1996 Jan; 27(1):60-6. PubMed ID: 8522711
[TBL] [Abstract][Full Text] [Related]
15. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters in haematology and oncology patients (PASSPORT 2).
Kumwenda MJ; Dougherty L; Jackson A; Hill S
J Vasc Access; 2021 Jul; 22(4):568-574. PubMed ID: 32867568
[TBL] [Abstract][Full Text] [Related]
16. Review and update of the use of urokinase in the prevention and management of CVAD-related complications in pediatric oncology patients.
Simon A; Bode U; Lieber K; Beutel K; Fleischhack G
Am J Infect Control; 2008 Feb; 36(1):54-8. PubMed ID: 18241737
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
Bagnall HA; Gomperts E; Atkinson JB
Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
[TBL] [Abstract][Full Text] [Related]
18. Urokinase administration in pediatric patients with occluded central venous catheters.
Wachs T
J Intraven Nurs; 1990; 13(2):100-2. PubMed ID: 2313458
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
[TBL] [Abstract][Full Text] [Related]
20. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
Ouriel K; Kandarpa K; Schuerr DM; Hultquist M; Hodkinson G; Wallin B
J Vasc Interv Radiol; 1999 Sep; 10(8):1083-91. PubMed ID: 10496712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
